KATY, TX / ACCESS Newswire / July 1, 2026 / In the wave of precision medicine development and accelerated iteration of life science technology, immunofluorescence (IF) technology has become a core ...

Shares of Passage Bio slid after the company signed an all-stock deal to merge with Remix Therapeutics, taking the latter company public. Shares were down 16% to $4.93 in after-hours trading, after ...

Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation July 6, 2026 9:30 AM ...

Praxis Precision Medicines, Inc. Strong Buy: key PDUFA dates, NDA catalysts in rare CNS, BTD elsunersen data, and strong cash ...

Proscia ® today introduced the Fifth Generation of its Concentriq ® 1 platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to ...

The positive case for AI has been criminally underrepresented in the public debate, write the director and an economist at ...

Cancer treatment is being transformed. Scientists can now identify the specific genetic mutations that drive a patient’s ...

According to a research report by Mordor Intelligence, the citric acid market is projected to grow from USD 3.93 billion in 2026 to USD 4.81 billion by 2031, registering a CAGR of 4.12% during the ...

Stock futures pointed to a mixed open on the last trading day of the week before the July 4 holiday, as Wednesday's slide in tech stocks extended . into Asia and Eu ...

CLEVELAND, Ohio - In this election year, statehouse Republicans are taking on populist issues from property taxes to data ...

Indian equity markets ended higher on Wednesday as benchmark indices recovered sharply, supported by gains in banking and IT ...

Most U.S. stocks rose, and the Dow Jones Industrial Average set another record, but more drops for chip stocks and other AI winners kept indexes mixed. The S&P 500 finished basically unchanged on ...